Old Web
English
Sign In
Acemap
>
Paper
>
P61.02 MCL1 Inhibition Enhances the Therapeutic Effect of MEK Inhibitors in KRAS-Mutant Lung Adenocarcinoma Cells
P61.02 MCL1 Inhibition Enhances the Therapeutic Effect of MEK Inhibitors in KRAS-Mutant Lung Adenocarcinoma Cells
2021
M. Tada
Toshiyuki Sumi
Y. Tanaka
S Hirai
M. Yamaguchi
M Miyajima
H Takahashi
A. Watanabe
Y. Sakuma
Keywords:
Medicine
KRAS
Mutant
Cancer research
Therapeutic effect
MCL1
Lung
Adenocarcinoma
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]